PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 36.17% | 56.87% | 51.72% | 40.94% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.17% | 56.87% | 51.72% | 40.94% | -- |
| Cost of Revenue | 38.68% | 59.19% | 56.81% | 43.94% | -- |
| Gross Profit | 28.54% | 49.95% | 37.37% | 32.50% | -- |
| SG&A Expenses | 54.02% | 64.32% | 71.34% | 85.74% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.48% | 60.73% | 60.01% | 51.76% | -- |
| Operating Income | -85.52% | -4.87% | -43.75% | -62.88% | -- |
| Income Before Tax | -88.86% | -8.84% | -43.47% | -63.90% | -- |
| Income Tax Expenses | -131.54% | -35.70% | -85.68% | -90.38% | -- |
| Earnings from Continuing Operations | -71.06% | 2.25% | -23.06% | -52.36% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.06% | 2.25% | -23.06% | -52.36% | -- |
| EBIT | -85.52% | -4.87% | -43.75% | -62.88% | -- |
| EBITDA | -38.80% | 27.07% | -23.22% | -45.16% | -- |
| EPS Basic | -70.92% | 2.27% | -22.99% | -52.38% | -- |
| Normalized Basic EPS | -77.92% | -1.06% | -39.38% | -60.54% | -- |
| EPS Diluted | -70.92% | 2.27% | -22.99% | -52.38% | -- |
| Normalized Diluted EPS | -77.92% | -1.06% | -39.38% | -60.54% | -- |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |